Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study
COBRA-BPS
Feasibility Study for a Cluster Randomized Trial on Integrated Primary Care Strategies to Reduce High Blood Pressure (Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study)
1 other identifier
interventional
453
3 countries
3
Brief Summary
High blood pressure (BP) is the leading attributable risk for cardiovascular disease (CVD). In rural South Asia, hypertension remains to be a significant public health issue with sub-optimal rates of case finding and management. A trial to investigate integrated primary care strategies to control hypertension is planned. Packaged interventions for the planned full-scale study are varying combinations of 1) home health education (HHE) by trained community health workers (CHW), 2) trained government primary health centre mid-level providers (MLP) led care and 3) trained private practitioners. The goal of the full-scale study is to test which combination of the above interventions is the most effective in lowering blood pressure among adults with hypertension in rural communities. In addition, the full-scale study aims to quantify the incremental cost- effectiveness of each approach in terms of cost per projected cardiovascular disease (CVD) disability adjusted life-years (DALYs) averted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Aug 2014
Shorter than P25 for not_applicable hypertension
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 28, 2014
CompletedFirst Posted
Study publicly available on registry
January 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFebruary 6, 2025
February 1, 2025
9 months
December 28, 2014
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
retention rate
proportion of hypertensive individuals followed up at 3 months in 3 countries
3 months
Secondary Outcomes (4)
Fidelity measure- Proportion of providers trained
3 months
Fidelity measure- home health education sessions delivered
3 months
fidelity measure 3- physician management checklist collected
3 months
Baseline to follow-up change in systolic blood pressure level
3 months
Study Arms (2)
Multicomponent "combination"
EXPERIMENTALMulticomponent intervention is a combination of the following 1) community health worker (CHW)- led blood pressure (BP) screening and referral to provider, plus 2) home health education (HHE) adapted to the local diet by trained CHW plus 3) trained primary health center mid-level providers (MLP) and physicians using evidence-based treatment algorithm of BP lowering in all and lipid lowering for high risk, plus 4) process-based incentives
Usual Care
NO INTERVENTIONNo active intervention
Interventions
Multicomponent intervention is a combination of the following 1) community health worker (CHW)- led blood pressure (BP) screening and referral to provider, plus 2) home health education (HHE) adapted to the local diet by trained CHW plus 3) trained primary health center mid-level providers (MLP) and physicians using evidence-based treatment algorithm of BP lowering in all and lipid lowering for high risk, plus 4) process-based incentives
Eligibility Criteria
You may qualify if:
- Age≥ 40 years
- Residing in the selected clusters
- Hypertension defined either as:
- persistently elevated BP (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg) from each set of 2 readings from 2 separate days
- maintained on anti-hypertensive medications
- Informed consent
You may not qualify if:
- Bed-ridden individuals too ill to commute to the clinic
- Individuals with advanced medical disease (on dialysis, liver failure, other systemic diseases)
- Individuals that are mentally compromised and unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke-NUS Graduate Medical Schoollead
- International Centre for Diarrhoeal Disease Research, Bangladeshcollaborator
- Aga Khan Universitycollaborator
- University of Kelaniyacollaborator
Study Sites (3)
Initiative for Non-Communicable Diseases icddr,b
Dhaka, Mohakhali, 1212, Bangladesh
Aga Khan University Hospital
Karachi, Karachi, 74800, Pakistan
University of Kelaniya
Ragama, Ragama, Sri Lanka
Related Publications (1)
Jafar TH, Silva Ad, Naheed A, Jehan I, Liang F, Assam PN, Legido-Quigley H, Finkelstein EA, Ebrahim S, Wickremasinghe R, Alam D, Khan AH; COBRA-BPS Study Group. Control of blood pressure and risk attenuation: a public health intervention in rural Bangladesh, Pakistan, and Sri Lanka: feasibility trial results. J Hypertens. 2016 Sep;34(9):1872-81. doi: 10.1097/HJH.0000000000001014.
PMID: 27488552DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tazeen H Jafar, MD, MPH
Duke-NUS, Singapore
- PRINCIPAL INVESTIGATOR
Aliya Naheed
Initiative for Non-Communicable Diseases icddr,b, Bangladesh
- PRINCIPAL INVESTIGATOR
Imtiaz Jehan
Aga Khan University
- PRINCIPAL INVESTIGATOR
Asita de Silva
University of Kelaniya, Sri Lanka
- PRINCIPAL INVESTIGATOR
Shah Ebrahim
London School of Hygiene and Tropical Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 28, 2014
First Posted
January 19, 2015
Study Start
August 1, 2014
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
February 6, 2025
Record last verified: 2025-02